Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Polar Capital Holdings Plc reported a 5.65% stake in Arcutis Biotherapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Polar Capital Holdings Plc reported a 5.65% stake in Arcutis Biotherapeutics, Inc., 6,706,475 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 5.65%
- Shares
- 6,706,475
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Polar Capital Holdings Plc | 5.65% | 6,706,475 |
| Polar Capital LLP | 5.65% | 6,706,475 |
| Polar Capital Funds PLC - Biotechnology Fund | 5.06% | 6,000,000 |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Polar Capital Holdings Plc
- Arcutis Biotherapeutics, Inc. shareholders
- Schedule 13G · Polar Capital Holdings Plc · Aug 14, 2026
- Schedule 13G/A · Polar Capital Holdings Plc · Aug 14, 2025
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026